Clinical Trial Update: Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic variability study evaluating two lots of E5501 administered to fed and fasted healthy subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia

Drugs mentioned

• E5501

Snippet

Sponsor: Eisai Inc. | Conditions: Purpura, Thrombocytopenic, Idiopathic, Acute Idiopathic Thrombocytopenic Purpura | Phase 1 | Status: COMPLETED